Improving the management of vaso-occlusive episodes in the pediatric emergency department

Pediatrics

Volumn 136, Issue 4, 2015, Pages e1016-e1025

  Kavanagh, Patricia L ^a   Sprinz, Philippa G ^a   Wolfgang, Tahlia L ^a   Killius, Kelly ^a   Champigny, Maria ^a   Sobota, Amy ^a   Dorfman, David ^a   Barry, Karan ^a   Miner, Renee ^a   Moses, James M ^a  

^a BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; OPIATE; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD VESSEL OCCLUSION; CHILD; CHILD CARE; CONTROLLED STUDY; EMERGENCY WARD; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; PEDIATRICS; PRIORITY JOURNAL; RESPIRATION DEPRESSION; SICKLE CELL ANEMIA; SINGLE DRUG DOSE; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; URBAN AREA; VASOOCCLUSIVE EPISODE; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; EMERGENCY HEALTH SERVICE; FEMALE; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PAIN; PATIENT EDUCATION; PRESCHOOL CHILD; STANDARDS; TIME; VASCULAR DISEASES; YOUNG ADULT;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ANALGESICS; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; EMERGENCY SERVICE, HOSPITAL; FEMALE; FENTANYL; HUMANS; INJECTIONS, INTRAVENOUS; MALE; PAIN; PATIENT EDUCATION AS TOPIC; QUALITY IMPROVEMENT; TIME FACTORS; TRIAGE; VASCULAR DISEASES; YOUNG ADULT;

EID: 84942908868     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-3470     Document Type: Article

References (31)

1. Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010; 38 (suppl 4): S512-S521
2. Brousseau DC, Panepinto JA, Nimmer M, Hoffmann RG. The number of people with sickle-cell disease in the United States: National and state estimates. Am J Hematol. 2010; 85 (1): 77-78
3. Smith WR, Penberthy LT, Bovbjerg VE, et al. Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008; 148 (2): 94-101
4. Yusuf HR, Atrash HK, Grosse SD, Parker CS, Grant AM. Emergency department visits made by patients with sickle cell disease: A descriptive study, 1999-2007. Am J Prev Med. 2010; 38 (suppl 4): S536-S541
5. Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD. Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States. Pediatr Blood Cancer. 2009; 53 (4): 642-646
6. National Heart Lung and Blood Institute. Evidence-based management of sickle cell disease: Expert panel report. National Institutes of Health. Available at: Www.nhlbi.nih.gov/health-pro/guidelines/sickle-cell-disease-guidelines/sickle-cell-disease-report.pdf. Accessed September 10, 2014
7. Benjamin LJ, Dampier CD, Jacox A, et al. Guideline for the Management of Acute and Chronic Pain in Sickle Cell Disease. Glenview, IL: American Pain Society; 1999
8. Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG. Quality-of-care indicators for children with sickle cell disease. Pediatrics. 2011; 128 (3): 484-493
9. Shenoi R, Ma L, Syblik D, Yusuf S. Emergency department crowding and analgesic delay in pediatric sickle cell pain crises. Pediatr Emerg Care. 2011; 27 (10): 911-917
10. Morrissey LK, Shea JO, Kalish LA, Weiner DL, Branowicki P, Heeney MM. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009; 52 (3): 369-372
11. Zempsky WT, Loiselle KA, McKay K, Lee BH, Hagstrom JN, Schechter NL. Do children with sickle cell disease receive disparate care for pain in the emergency department? J Emerg Med. 2010; 39 (5): 691-695
12. Kenyon CC, Kavanagh PL, Fiechtner LG, Textor TE, Wang CJ. Setting the agenda for quality improvement in pediatric sickle cell disease. J Natl Med Assoc. 2012; 104 (7-8): 337-341
13. Institute of Medicine. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research. Washington, DC: The National Academies Press; 2011
14. Zempsky WT. Treatment of sickle cell pain: Fostering trust and justice. JAMA. 2009; 302 (22): 2479-2480
15. Kremer E, Atkinson JH, Ignelzi RJ. Measurement of pain: Patient preference does not confound pain measurement. Pain. 1981; 10 (2): 241-248
16. Langley GJ. The Improvement Guide: A Practical Approach to Enhancing Organizational Performance. 2nd ed. San Francisco, CA: Jossey-Bass; 2009
17. Borland M, Jacobs I, King B, O'Brien D. A randomized controlled trial comparing intranasal fentanyl to intravenous morphine for managing acute pain in children in the emergency department. Ann Emerg Med. 2007; 49 (3): 335-340
18. Borland ML, Jacobs I, Geelhoed G. Intranasal fentanyl reduces acute pain in children in the emergency department: A safety and efficacy study. Emerg Med (Fremantle). 2002; 14 (3): 275-280
19. Hansen MS, Mathiesen O, Trautner S, Dahl JB. Intranasal fentanyl in the treatment of acute pain-A systematic review. Acta Anaesthesiol Scand. 2012; 56 (4): 407-419
20. Todd KH, Green C, Bonham VL Jr, Haywood C Jr, Ivy E. Sickle cell disease related pain: Crisis and conflict. J Pain. 2006; 7 (7): 453-458
21. Booker MJ, Blethyn KL, Wright CJ, Greenfield SM. Pain management in sickle cell disease. Chronic Illn. 2006; 2 (1): 39-50
22. Benneyan JC, Lloyd RC, Plsek PE. Statistical process control as a tool for research and healthcare improvement. Qual Saf Health Care. 2003; 12 (6): 458-464
23. Mohammed MA. Using statistical process control to improve the quality of health care. Qual Saf Health Care. 2004; 13 (4): 243-245
24. Givens M, Rutherford C, Joshi G, Delaney K. Impact of an emergency department pain management protocol on the pattern of visits by patients with sickle cell disease. J Emerg Med. 2007; 32 (3): 239-243
25. Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP. Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. Pediatr Emerg Care. 2004; 20 (1): 2-4
26. Barrett MJ, Cronin J, Murphy A, et al. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: Study protocol for a randomised controlled trial. Trials. 2012; 13 (1): 74
27. Holdgate A, Cao A, Lo KM. The implementation of intranasal fentanyl for children in a mixed adult and pediatric emergency department reduces time to analgesic administration. Acad Emerg Med. 2010; 17 (2): 214-217
28. Telfer P, Bahal N, Lo A, Challands J. Management of the acute painful crisis in sickle cell disease-A re-evaluation of the use of opioids in adult patients. Br J Haematol. 2014; 166 (2): 157-164
29. Charles D, Gabriel M, Furukawa MF. Adoption of Electronic Health Record Systems Among US Non-Federal Acute Care Hospitals: 2008-2013. Office of the National Coordinator for Health Information Technology Washington, DC. ONC Data Brief, No. 16. May 2014
30. Drendel AL, Brousseau DC, Gorelick MH. Pain assessment for pediatric patients in the emergency department. Pediatrics. 2006; 117 (5): 1511-1518
31. Gordon DB, Rees SM, McCausland MR, et al. Improving reassessment and documentation of pain management. Jt Comm J Qual Patient Saf. 2008; 34 (9): 509-517